Dear @hannahkuchler, as you are neck deep :) please find here what we developed for #cysticfibrosis applicable to #COVID19
Alaxia partners with University of Padua to evaluate ALX-009 inhalation solution against SARS-CoV-2 https://t.co/aDpOK5Y7MW #alx009#meveol#alaxia
Un espoir contre le COVID-19 : un candidat-médicament contre la mucoviscidose, développé à Lyon, agit aussi sur le virus https://t.co/1HWAHISlMZ @dr_l_alexandre